Results 131 to 140 of about 57,759 (194)

Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial. [PDF]

Lancet Oncol
Woodworth GF, Anastasiadis P, Ozair A, Chabros J, Bettegowda C, Chen C, Gerstl JVE, Douville C, Mekary RA, Smith TR, Meng Y, Hawkins C, Pople CB, Abrahao A, Llinas M, Heyn C, Bunevicius A, Rezai AR, Ball AJS, Henry K, Sahgal A, Torio E, Ren H, Ahmad H, Arora H, Eisenberg H, Perry J, Carpenter JS, Hynynen K, Pham LC, Anketell MB, Lim-Fat MJ, Xu Z, Cifarelli CP, Sheehan JP, McDannold NJ, Gandhi D, Golby AJ, Lipsman N.   +38 more
europepmc   +1 more source

Use of tumor treating fields for a malignant brain tumor in a pregnant woman: Case report. [PDF]

Brain Spine
Rubisoier L, Lustgarten L, Thomé C, Freyschlag CF, Kerschbaumer J.   +4 more
europepmc   +1 more source

Comparative analysis of streptozocin-based regimen and capecitabine-temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index. [PDF]

Ther Adv Med Oncol
Tabe Y, Ono H, Matsui S, Asano D, Ishikawa Y, Ueda H, Akahoshi K, Katsuta E, Ban D.   +8 more
europepmc   +1 more source

Survival Benefit of Temozolomide Plus Irinotecan as Second-Line Therapy in Small Cell Lung Cancer: A Retrospective Single-Center Study. [PDF]

J Clin Med
Acar O, Agaoglu AB, Sahbazlar M, Ekinci F, Erdogan AP.   +4 more
europepmc   +1 more source

Rethinking treatment de-escalation in elderly glioblastoma: Lessons from a multicenter real-world cohort. [PDF]

Neurooncol Adv
Furman O, Falah E, Dvir I, Satra-Shenes O, Bittan A, Bokstein F, Blumenthal DT, Taliansky A, Zach L.   +8 more
europepmc   +1 more source

Scalable tracking of symptoms in the electronic health record using large language models in patients with central nervous system cancers undergoing therapy. [PDF]

Neuro Oncol
Rhee JY, Tentor Z, Sounack T, Durieux B, Miller PJ, Beroukhim R, Lindvall C.   +6 more
europepmc   +1 more source

AquIRE reveals the mechanisms of clinically induced RNA damage and the conservation and dynamics of glycoRNAs. [PDF]

Nucleic Acids Res
Zhang Z, Kotopanova ZV, Dang K, Kong X, Simms N, Yuen TW, Lam L, Beadle LF, Hilton E, Qureshi T, Coppola M, Holmes CD, Kan KT, Ashe M, Gallois P, Ashe H, Braun M, Saunders M, Sutton P, Thornton DJ, Knight JRP.   +20 more
europepmc   +1 more source

Gliosarcoma: A Case Series and Comprehensive Literature Review. [PDF]

Cureus
Aguilar Mora HM, Barrera Roman LK, Reyes Soto G, Castillo-Rangel C, Agis Ocaña JG, Ramirez ME, Acosta Garcés R.   +6 more
europepmc   +1 more source

Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation histological grade 2/3 gliomas: An extension retrospective analysis of a randomized controlled trial. [PDF]

Cancer
Zhang J, Wang P, Ren Y, Chen L, Feng J, Liu F, Deng K, Bao Z, Qiu X, Liu Y.   +9 more
europepmc   +1 more source

Hypoxia-induced PRMT6 expression promotes temozolomide chemoresistance in glioblastoma via G3BP1. [PDF]

J Transl Med
Chen S, Yu P, Sun Y, Yan Y, Zhang B, Li G.   +5 more
europepmc   +1 more source